Early Laparoscopic Cholecystectomy Versus Percutaneous Cholecystostomy in Grade II Acute Cholecystitis Guidelines
Launched by ALEXANDRIA UNIVERSITY · Jul 17, 2021
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
A-Study setting: Department of Surgery, main university hospital, Faculty of Medicine, Alexandria University, Egypt. The study was approved by the Ethics Committee of our institution.
B-Study design: Retrospective clinical trial C-Study subjects: The target population are patients with preoperative diagnosis of grade II acute cholecystitis Those patients were subjected to surgery either early laparoscopic cholecystectomy or delayed laparoscopic cholecystectomy after percutaneous cholecystostomy
Inclusion criteria of the study patients:
-Specific written informed consent approved by our I...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with one of the criteria stated by grade II (moderate) Tokyo guidelines for acute cholecystitis who were managed either by early LC or by a bridging PC followed by delayed LC.
- Exclusion Criteria:
- • grade I or III acute cholecystitis
- • common bile duct stones or jaundice,
- • Liver cirrhosis,
- • severe upper abdominal adhesions,
- • acalculous cholecystitis
- • major comorbidities in which laparoscopic surgery is contraindicated.
- • those who followed a conservative treatment for acute cholecystitis
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Alexandria, , Egypt
Alexandria, , Egypt
Patients applied
Trial Officials
HANY MK EL-HADDAD, professor
Principal Investigator
alexandria university, faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials